IRVINE, CA--(Marketwired - Jul 25, 2013) - BIOLASE, Inc. (
Dr. Krespi is Clinical Professor of Otolaryngology at Columbia University and founding member of the New York Head & Neck Institute, where he also chairs the Sleep Disorders Center. Valam has been the vehicle over the years for him to place his innovations in ENT laser concepts, including lasers for sinusitis, laser microbial killing / biofilm disruption, and the use of lasers for treating halitosis. "The Valam team is very excited about this strategic relationship, we could not think of a better corporate partner than BIOLASE to launch laser products that are the culmination of years of ENT-specific surgical laser research and development," said Dr. Krespi of Valam.
Federico Pignatelli, Chairman and Chief Executive Officer of BIOLASE, said, "We look forward to being able to offer an elegant, simple-to-use, precision laser-based biologic cutting tool to the 9,000 practicing otolaryngologists in the United States. BIOLASE has planned to enter the ENT market with a clinical laser product offering. Valam and Dr. Krespi give us the opportunity to enter the ENT space with a robust product and a thought-leader in the field as our initial spokesperson and product champion."
"Our partnership with Valam includes an exclusive worldwide license to all of Valam's ENT-related patents and pending patents, which when combined with BIOLASE's existing ENT laser-related patents, creates a formidable patent estate," said Alexander K. Arrow, MD, President and Chief Operating Officer of BIOLASE. "BIOLASE plans to hire a small specialized ENT sales force in advance of our ENT launch, which could occur as soon as the fourth quarter of this year."
About Valam Corporation Valam Corporation was founded in 2005, by Yosef Krespi, M.D., F.A.C.S. to pursue light and laser based antimicrobial and biofilm destruction therapies. Valam is headquartered in New York, NY, with technology development facilities in Europe and Israel. Valam has built a strong and internationally recognized board of directors and a team of medical, scientific and technical experts who are committed to its success.
About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine . The Company's proprietary laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaginative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com , Facebook at www.facebook.com/biolaseinc , Twitter at www.twitter.com/biolaseinc , Pinterest at www.pinterest.com/biolase , LinkedIn at www.linkedin.com/company/biolase , Instagram at www.instagram.com/biolaseinc and YouTube at www.youtube.com/biolasevideos .
BIOLASE ® , WaterLase ® , and EPIC™ are registered trademarks or trademarks of BIOLASE, Inc.
For further information, please contact: Michael Porter Porter, LeVay & Rose, Inc. 212-564-4700
